Biofrontera AG (ETR:B8FK)
2.550
-0.050 (-1.92%)
Mar 9, 2026, 9:13 AM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €15.86 million as of March 9, 2026. Its market cap has increased by 8.52% in one year.
Market Cap
15.86M
Enterprise Value
12.94M
Revenue
23.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.55
Market Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 15.86M, a decrease of -58.31%. That is a compound annual growth rate of -4.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 15.86M | 6.97% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 47.89B |
| Siemens Healthineers AG | 45.09B |
| Bayer Aktiengesellschaft | 35.75B |
| Fresenius SE & Co. KGaA | 26.32B |
| Cantourage Group SE | 58.98M |
| Pentixapharm Holding AG | 49.94M |
| MeVis Medical Solutions AG | 44.77M |
| aap Implantate AG | 20.45M |